The BSE Sensex, is set to rise slightly over the next year but remain well below the record highs expected just three months ago, a Reuters poll found.
Shares of Sun Pharma Advanced Research Company today fell by almost 3 per cent as the US health regulator has revoked its earlier approval of its new drug application for Elepsia XR, an anti-epileptic drug.
The watchdog had earlier ordered attachment of bank and demat accounts of the company to recover the penalties imposed for violation of capital market norms.